\
&
Contact us
\
&
Contact us
This was 4 months ago
LocationWebinar
ProgrammesMrs. Ester Hortet Tarroja, legal advisor of the Common Legal Support Centre of DG Research and Innovation of the European Commission, will shed a light on the Means of redress in Horizon Europe.
There will be enough time for your questions towards the speaker and/or the audience.
There is no need to register, simply join the webinar by clicking on this TEAMS link.
The webinar is organized by BE-ARMA, the Belgian Association of Research Managers and Administrators in European funded projects. If you want to be part of this community and get access to peer-to-peer interaction, join the BE-ARMA MS Teams.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
